New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer

被引:12
|
作者
Chiaradonna, Ferdinando [1 ,2 ]
Cirulli, Claudia [1 ,2 ]
Palorini, Roberta [1 ,2 ]
Votta, Giuseppina [1 ,2 ]
Alberghina, Lilia [1 ,2 ]
机构
[1] SYSBIO Ctr Syst Biol, Milan, Italy
[2] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy
关键词
TRANSCRIPTION FACTOR YY1; DEPENDENT PROTEIN-KINASE; ACUTE MYELOID-LEUKEMIA; YIN YANG 1; C-MYC; TUMOR-SUPPRESSOR; LYSINE ACETYLATION; PYRUVATE-KINASE; SKELETAL-MUSCLE; GENE-EXPRESSION;
D O I
10.1089/ars.2014.5854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Histone deacetylases (HDACs) activity and cell metabolism are considered important targets for cancer therapy, as both are deregulated and associated with the onset and maintenance of tumors. Recent Advances: Besides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus. Importantly, recent high-throughput studies have identified as important target proteins several enzymes involved in different metabolic pathways. Conversely, it has been also shown that metabolic intermediates may control HDACs activity. Consequently, the acetylation/deacetylation of metabolic enzymes and the ability of metabolic intermediates to modulate HDACs may represent a cross-talk connecting cell metabolism, transcription, and other HDACs-controlled processes in physiological and pathological conditions. Critical Issues: Since metabolic alterations and HDACs deregulation are important cancer hallmarks, disclosing connections among them may improve our understanding on cancer mechanisms and reveal novel therapeutic protocols against this disease. Future Directions: High-throughput metabolic studies performed by using more sophisticated technologies applied to the available models of conditional deletion of HDACs in cell lines or in mice will fill the gap in the current understanding and open directions for future research. Antioxid. Redox Signal. 23, 30-50.
引用
收藏
页码:30 / 50
页数:21
相关论文
共 50 条
  • [31] Insights into the connection between cancer and alternative splicing
    Kim, Eddo
    Goren, Amir
    Ast, Gil
    TRENDS IN GENETICS, 2008, 24 (01) : 7 - 10
  • [32] HISTONE DEACETYLASES INHIBITORS: A NEW FRONTIER FOR NEUROPROTECTION?
    Squarzoni, Angelica
    Donzelli, Elisabetta
    Alberti, Paola
    Ballarini, Elisa
    Rodriguez-Menendez, Virginia
    Scuteri, Arianna
    Cavaletti, Guido
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S46 - S46
  • [33] A role for histone deacetylases in regulation of Aspergillus nidulans secondary metabolism
    Shwab, E.
    Bok, J.
    Tribus, M.
    Galehr, J.
    Graessle, S.
    Keller, N.
    PHYTOPATHOLOGY, 2005, 95 (06) : S96 - S96
  • [34] Fatty acid metabolism at the connection of histone methylation and mammary cell plasticity
    Yadav, Shivangi
    Virk, Ranya Ka
    Chung, Carolina H.
    Chandrasekaran, Sriram
    Backman, Vadim
    Khan, Seema Ahsan
    Clare, Susan Elizabeth
    CANCER RESEARCH, 2021, 81 (04)
  • [35] The role of histone deacetylases in cardiac energy metabolism in heart diseases
    Yu, Qingwen
    Zhao, Guangyuan
    Liu, Jingjing
    Peng, Yajie
    Xu, Xueli
    Zhao, Fei
    Shi, Yangyang
    Jin, Chengyun
    Zhang, Ji
    Wei, Bo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142
  • [36] The sirtuin class of histone deacetylases: Regulation and roles in lipid metabolism
    Fiorino, Erika
    Giudici, Marco
    Ferrari, Alessandra
    Mitro, Nico
    Caruso, Donatella
    De Fabiani, Emma
    Crestani, Maurizio
    IUBMB LIFE, 2014, 66 (02) : 89 - 99
  • [37] THE SCLERODERMA-CANCER CONNECTION: NEW INSIGHTS
    Rosen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 43 - 44
  • [38] Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin
    Wade, PA
    HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 693 - 698
  • [39] Class II histone deacetylases at the interface between metastasis and drug resistance in cancer cells
    Chu, Fei
    Qiu, Yiyong
    Clark, Sandra
    Mirkin, Bernard
    Madonna, Mary Beth
    CANCER RESEARCH, 2009, 69
  • [40] Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer
    Legare, Stephanie
    Basik, Mark
    MOLECULAR ENDOCRINOLOGY, 2016, 30 (09) : 965 - 976